Pharming Group (PHARM) Financial Statements

27 Followers

Pharming Group Financial Overview

Pharming Group's market cap is currently €1.08B. The company's EPS TTM is €0.005930122800000001; its P/E ratio is 347.84; Pharming Group is scheduled to report earnings on March 12, 2026, and the estimated EPS forecast is €0.00. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 391.47M	$ 286.89M	$ 245.32M	$ 205.62M	$ 189.85M
Gross Profit	$ 344.11M	$ 231.82M	$ 220.10M	$ 188.06M	$ 169.67M
Operating Income	$ 20.10M	$ -3.39M	$ -4.88M	$ 18.23M	$ 27.84M
EBITDA	$ 31.77M	$ 13.18M	$ 9.88M	$ 33.53M	$ 48.78M
Net Income	$ 2.97M	$ -10.64M	$ -10.55M	$ 13.67M	$ 16.00M
Balance Sheet
Cash & Short-Term Investments	$ 179.88M	$ 162.07M	$ 213.42M	$ 207.34M	$ 191.72M
Total Assets	$ 500.02M	$ 386.88M	$ 462.85M	$ 425.80M	$ 396.90M
Total Debt	$ 115.79M	$ 108.42M	$ 171.54M	$ 166.69M	$ 161.59M
Net Debt	$ -30.29M	$ 55.38M	$ 109.80M	$ -40.65M	$ -30.13M
Total Liabilities	$ 222.89M	$ 172.72M	$ 244.07M	$ 221.16M	$ 204.19M
Stockholders' Equity	$ 277.10M	$ 214.16M	$ 218.78M	$ 204.64M	$ 192.72M
Cash Flow
Free Cash Flow	$ 51.18M	$ -2.50M	$ -18.77M	$ 20.92M	$ 20.17M
Operating Cash Flow	$ 51.96M	$ -1.73M	$ -17.30M	$ 22.90M	$ 36.13M
Investing Cash Flow	$ 19.13M	$ 31.62M	$ -129.39M	$ 5.32M	$ -20.34M
Financing Cash Flow	$ 15.03M	$ -34.41M	$ -1.04M	$ -4.98M	$ -26.68M

Currency in USD

Pharming Group Earnings and Revenue History

Income Statement >

Pharming Group Debt to Assets

Balance Sheet >

Pharming Group Cash Flow

Cash Flow >

Pharming Group Forecast EPS vs Actual EPS

Earnings >